YU269176A - Process for the manufacture of new 6-aryl-s-triazolo-(4,3-a)-pyrido-(2,3-f)-4-diazepine - Google Patents
Process for the manufacture of new 6-aryl-s-triazolo-(4,3-a)-pyrido-(2,3-f)-4-diazepineInfo
- Publication number
- YU269176A YU269176A YU02691/76A YU269176A YU269176A YU 269176 A YU269176 A YU 269176A YU 02691/76 A YU02691/76 A YU 02691/76A YU 269176 A YU269176 A YU 269176A YU 269176 A YU269176 A YU 269176A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- diazepine
- triazolo
- pyrido
- aryl
- manufacture
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT837275A AT350056B (de) | 1975-11-04 | 1975-11-04 | Verfahren zur herstellung von neuen pyrido- (2,3-f)-(1,4)-diazepinen, deren optischen isomeren und salzen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| YU269176A true YU269176A (en) | 1983-02-28 |
Family
ID=3604891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU02691/76A YU269176A (en) | 1975-11-04 | 1976-11-02 | Process for the manufacture of new 6-aryl-s-triazolo-(4,3-a)-pyrido-(2,3-f)-4-diazepine |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US4110455A (sv) |
| JP (1) | JPS5831351B2 (sv) |
| AR (3) | AR217814A1 (sv) |
| AT (1) | AT350056B (sv) |
| AU (1) | AU504228B2 (sv) |
| BE (1) | BE847952A (sv) |
| CA (1) | CA1076111A (sv) |
| CH (1) | CH630920A5 (sv) |
| CS (1) | CS191181B2 (sv) |
| DD (1) | DD128178A5 (sv) |
| DE (1) | DE2649116A1 (sv) |
| DK (1) | DK142324B (sv) |
| EG (1) | EG12280A (sv) |
| ES (2) | ES452969A1 (sv) |
| FI (1) | FI62088C (sv) |
| FR (1) | FR2330404A1 (sv) |
| GB (1) | GB1562800A (sv) |
| HU (1) | HU177422B (sv) |
| IL (1) | IL50816A (sv) |
| IN (1) | IN144289B (sv) |
| MX (1) | MX4284E (sv) |
| NL (1) | NL7612187A (sv) |
| NO (1) | NO146470C (sv) |
| PL (2) | PL113803B1 (sv) |
| PT (1) | PT65787B (sv) |
| RO (2) | RO77294A (sv) |
| SE (1) | SE7612260L (sv) |
| SU (2) | SU667137A3 (sv) |
| YU (1) | YU269176A (sv) |
| ZA (1) | ZA766620B (sv) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1185601A (en) * | 1981-02-27 | 1985-04-16 | Walter Hunkeler | Imidazodiazepines |
| DE3435973A1 (de) * | 1984-10-01 | 1986-04-10 | Boehringer Ingelheim KG, 6507 Ingelheim | Diazepine enthaltende pharmazeutische zusammensetzungen mit paf-antagonistischer wirkung |
| US4798896A (en) * | 1988-01-19 | 1989-01-17 | American Home Products Corporation | Antipsychotic gamma-carboline N-oxides |
| US8541407B2 (en) | 2010-03-31 | 2013-09-24 | Arqule, Inc. | Substituted benzo-pyrido-triazolo-diazepine compounds |
| WO2012075456A1 (en) | 2010-12-02 | 2012-06-07 | Constellation Pharmaceuticals | Bromodomain inhibitors and uses thereof |
| AR084070A1 (es) | 2010-12-02 | 2013-04-17 | Constellation Pharmaceuticals Inc | Inhibidores del bromodominio y usos de los mismos |
| WO2012151512A2 (en) | 2011-05-04 | 2012-11-08 | Constellation Pharmaceuticals, Inc. | Bromodomain inhibitors and uses thereof |
| EP2721031B1 (en) | 2011-06-17 | 2016-01-20 | Constellation Pharmaceuticals, Inc. | Bromodomain inhibitors and uses thereof |
| WO2013184878A1 (en) | 2012-06-06 | 2013-12-12 | Constellation Pharmaceuticals, Inc. | Benzo [b] isoxazoloazepine bromodomain inhibitors and uses thereof |
| TWI602820B (zh) | 2012-06-06 | 2017-10-21 | 星宿藥物公司 | 溴域抑制劑及其用途 |
| US9969747B2 (en) | 2014-06-20 | 2018-05-15 | Constellation Pharmaceuticals, Inc. | Crystalline forms of 2-((4S)-6-(4-chlorophenyl)-1-methyl-4H-benzo[C]isoxazolo[4,5-e]azepin-4-yl)acetamide |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT327917B (de) * | 1973-04-12 | 1976-02-25 | Degussa | Verfahren zur herstellung von neuen 5-aryl-pyrido- (b-6,7) -1,4-diazepinen und deren salzen |
| US4039551A (en) * | 1976-03-15 | 1977-08-02 | The Upjohn Company | 1-[(Hydroxyamino)methyl]-6-aryl-4H-s-triazolo[4,3-a][1,4]benzodiazepines |
-
1975
- 1975-11-04 AT AT837275A patent/AT350056B/de not_active IP Right Cessation
-
1976
- 1976-06-02 RO RO7697708A patent/RO77294A/ro unknown
- 1976-10-26 US US05/735,894 patent/US4110455A/en not_active Expired - Lifetime
- 1976-10-26 SU SU762414098A patent/SU667137A3/ru active
- 1976-10-27 FR FR7632326A patent/FR2330404A1/fr active Granted
- 1976-10-28 DE DE19762649116 patent/DE2649116A1/de not_active Withdrawn
- 1976-11-02 GB GB45476/76A patent/GB1562800A/en not_active Expired
- 1976-11-02 YU YU02691/76A patent/YU269176A/xx unknown
- 1976-11-02 DD DD7600195560A patent/DD128178A5/xx unknown
- 1976-11-02 IL IL50816A patent/IL50816A/xx unknown
- 1976-11-02 EG EG76673A patent/EG12280A/xx active
- 1976-11-03 MX MX765041U patent/MX4284E/es unknown
- 1976-11-03 PL PL1976193439A patent/PL113803B1/pl unknown
- 1976-11-03 DK DK497076AA patent/DK142324B/da not_active IP Right Cessation
- 1976-11-03 PL PL1976223070A patent/PL118308B1/pl unknown
- 1976-11-03 SE SE7612260A patent/SE7612260L/sv not_active Application Discontinuation
- 1976-11-03 AR AR265336A patent/AR217814A1/es active
- 1976-11-03 CH CH1386976A patent/CH630920A5/de not_active IP Right Cessation
- 1976-11-03 NO NO763739A patent/NO146470C/no unknown
- 1976-11-03 ES ES452969A patent/ES452969A1/es not_active Expired
- 1976-11-03 PT PT65787A patent/PT65787B/pt unknown
- 1976-11-03 RO RO7688309A patent/RO70245A/ro unknown
- 1976-11-03 BE BE6045743A patent/BE847952A/xx unknown
- 1976-11-03 FI FI763158A patent/FI62088C/fi not_active IP Right Cessation
- 1976-11-03 NL NL7612187A patent/NL7612187A/xx not_active Application Discontinuation
- 1976-11-03 CS CS767096A patent/CS191181B2/cs unknown
- 1976-11-03 HU HU76DE927A patent/HU177422B/hu unknown
- 1976-11-03 ES ES452971A patent/ES452971A1/es not_active Expired
- 1976-11-04 JP JP51132728A patent/JPS5831351B2/ja not_active Expired
- 1976-11-04 ZA ZA766620A patent/ZA766620B/xx unknown
- 1976-11-04 AU AU19311/76A patent/AU504228B2/en not_active Expired
- 1976-11-04 CA CA264,849A patent/CA1076111A/en not_active Expired
- 1976-11-17 IN IN2062/CAL/76A patent/IN144289B/en unknown
-
1977
- 1977-06-14 AR AR268053A patent/AR216916A1/es active
- 1977-06-14 AR AR268052A patent/AR216915A1/es active
- 1977-10-17 SU SU772532701A patent/SU676165A3/ru active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU19876A (en) | Process for obtaining 1,2,3-thiadiazolyl-carbamide | |
| BG29722A3 (en) | Method for obtaining of 2, 5- disubstituated pyrimidin- 4- on | |
| PT65017B (en) | Process for the preparation of 1,1,1-triaryl-alkylamines | |
| YU269176A (en) | Process for the manufacture of new 6-aryl-s-triazolo-(4,3-a)-pyrido-(2,3-f)-4-diazepine | |
| YU42129B (en) | Process for making 3,4-dideoxicanomicyne b | |
| BG27547A3 (en) | Method of obtaining of 1,4- diphenyl- 3- pyrasoline- 5- ones | |
| YU39481B (en) | Process for the manufacture of 1-alkyl-1-(beta-alkoxycarboethyl)-1,2,3,4,6,7,12,12b-octahydroindolo(2,3-a)-quinolizine | |
| HU175728B (hu) | Sposob poluchenija 13,14-degidro-11-dezoksi-prostagland | |
| ZA764582B (en) | Process for the manufacture of cyclohexandione-1,3 | |
| PT65030A (en) | Process for the preparation of novel 4,4-diaryl-2-hydroxybutylamines | |
| HU173708B (hu) | Sposob poluchenija geterokolloidnogo 18-arabinozil-2-n-butil-3,7,11,15,19,21,23,27,25,37-dekagidroksi-4,16,32,34,36-pentametil-tetrakona-16,32-dien-35-0-lakton-40-guanidiniumsul'fata | |
| PT65256A (en) | Process for the preparation of 1-acyl-1,2,3,4-tetrahydro-6-quinolinols | |
| ZA764087B (en) | Continuous production of 2,5-dioxo-1-oxa-2-phospholanes | |
| GB1551120A (en) | Process for the manufacture of 16-20-keto-steroids | |
| ZA764890B (en) | Production of n,m-diethyl 2 (alpha-naphthoxy) propionamid | |
| GB1548670A (en) | Pricess for the production of 2-amino-3-hydroxypyridines | |
| IL50046A (en) | Process for the manufacture of 7,8-epoxy-2-methyloctadecane | |
| CH611631A5 (en) | Process for the preparation of 11,12-unsaturated 9alpha-fluorosteroids | |
| HU174155B (hu) | Sposob poluchenija 2,4-diamino-5-benzil-pirimidinov | |
| GB1554468A (en) | Manufacture of 2,6,6-trimethyl-cyclohex-2 en-1-one | |
| YU41293B (en) | Process for the producing of 3,4-dideoxy-kanamycin b | |
| HU172068B (hu) | Sposob asimmetricheskogo sinteza oktagidro-indolo/2,3-a/ khinolizidinov | |
| IL49689A (en) | Process for the preparation of 1,1-dihalo-1,3-alkadienes | |
| CH608004A5 (en) | Process for the preparation of 3,5-diphenylpyrazoles | |
| GB1487167A (en) | Process for the preparation of pure 1,5-dinitroanthraquinone |